Unknown

Dataset Information

0

Regulation of neuronal APL-1 expression by cholesterol starvation.


ABSTRACT:

Background

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of ?-amyloid plaques composed primarily of the amyloid-? peptide, a cleavage product of amyloid precursor protein (APP). While mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), sporadic AD has only one clear genetic modifier: the ?4 allele of the apolipoprotein E (ApoE) gene. Cholesterol starvation in Caenorhabditis elegans leads to molting and arrest phenotypes similar to loss-of-function mutants of the APP ortholog, apl-1 (amyloid precursor-like protein 1), and lrp-1 (lipoprotein receptor-related protein 1), suggesting a potential interaction between apl-1 and cholesterol metabolism.

Methodology/principal findings

Previously, we found that RNAi knock-down of apl-1 leads to aldicarb hypersensitivity, indicating a defect in synaptic function. Here we find the same defect is recapitulated during lrp-1 knock-down and by cholesterol starvation. A cholesterol-free diet or loss of lrp-1 directly affects APL-1 levels as both lead to loss of APL-1::GFP fluorescence in neurons. However, loss of cholesterol does not affect global transcription or protein levels as seen by qPCR and Western blot.

Conclusions

Our results show that cholesterol and lrp-1 are involved in the regulation of synaptic transmission, similar to apl-1. Both are able to modulate APL-1 protein levels in neurons, however cholesterol changes do not affect global apl-1 transcription or APL-1 protein indicating the changes are specific to neurons. Thus, regulation of synaptic transmission and molting by LRP-1 and cholesterol may be mediated by their ability to control APL-1 neuronal protein expression.

SUBMITTER: Wiese M 

PROVIDER: S-EPMC3283687 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of neuronal APL-1 expression by cholesterol starvation.

Wiese Mary M   Antebi Adam A   Zheng Hui H  

PloS one 20120221 2


<h4>Background</h4>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of β-amyloid plaques composed primarily of the amyloid-β peptide, a cleavage product of amyloid precursor protein (APP). While mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), sporadic AD has only one clear genetic modifier: the ε4 allele of the apolipoprotein E (ApoE) gene. Cholesterol starvation in Caenorhabditis elegans leads to molting and arrest phenotyp  ...[more]

Similar Datasets

| S-EPMC3698849 | biostudies-literature
| S-EPMC8706473 | biostudies-literature
| S-EPMC390341 | biostudies-literature
| S-EPMC5504187 | biostudies-literature
| S-EPMC3154699 | biostudies-literature
| S-EPMC3664916 | biostudies-literature
| S-EPMC5983599 | biostudies-literature
| S-EPMC5114704 | biostudies-literature
| S-EPMC10320512 | biostudies-literature
| S-EPMC4360921 | biostudies-literature